-- EPS Creative Health Technology (HKG:3860) unit EP Trading entered into a framework purchase agreement with EPS Americas to procure laboratory consumables for three years through March 2029, according to a Monday Hong Kong bourse filing.
Shares of the firm were up nearly 2% in Tuesday morning trade.
The agreement replaces a prior arrangement that expired on March 31 and covers products, including animal testing consumables such as purified diets, bedding, cages, and related supplies.
Proposed annual caps are set at HK$33 million for 2027, HK$36 million for 2028, and HK$39 million for 2029.
EPS Americas is a subsidiary of the company's controlling shareholder, EPS Holdings, the filing said.